HTRA3 and liver cancer: Interestingly, higher expression of POSTN (OS HR = 1.63, 95% CI = 1.13–2.33, p = 0.0076; DSS HR = 1.8, 95% CI = 1.11–2.93, p = 0.016; Figure 3A), LAYN (DSS HR = 1.61, 95% CI = 1.02–2.55, p = 0.039; Figure 3B) and HTRA3 (OS HR = 1.53, 95% CI = 1.08–2.17, p = 0.015) were associated with poorer outcomes in liver cancer (Figure 3C).